Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management

<table>Papulopustules on irradiated area. A 65-year-old-man with non-small-cell lung cancer stage IV and cauda equina syndrome was admitted for radiation. Erlotinib was given 7 days ago. After 2 days of radiotherapy he developed papulopustular eruption predominantly on the irradiation field.</table>

Dermatology Research and Practice

fig5

Figure 5

Figure 5: Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management 